|
Commitments And Contingencies (Schedule of Investments Under Securities Purchase Agreement And RELO) (Details) (USD $)
|
0 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 26, 2013
|
Dec. 07, 2012
|
Dec. 04, 2012
|
Mar. 31, 2011
|
Jan. 19, 2011
|
Jun. 30, 2010
|
Feb. 12, 2010
|
Oct. 23, 2009
|
Sep. 21, 2009
|
Jun. 05, 2009
|
Mar. 20, 2008
|
Dec. 18, 2007
|
May 13, 2006
|
Dec. 02, 2005
|
Aug. 08, 2005
|
May 10, 2001
|
Sep. 30, 2013
|
Dec. 31, 2012
|
|
| Shares issued | 11,400,000 | 2,083,333 | 19,130,435 | 8,333,333 | 2,334,515 | 6,666,667 | 300,000 | 6,072,383 | 3,102,837 | 2,857,143 | 642,858 | 4,857,159 | 3,850,000 | 650,000 | 4,175,000 | 3,600,000 | ||
| Deferred Research and Development Arrangement (note 8) | $ 1,165,429 | $ 1,626,000 | ||||||||||||||||
|
Teva Pharmaceutical Industries, Ltd. [Member]
|
||||||||||||||||||
| Deferred Research and Development Arrangement (note 8) | $ 471,679 | $ 876,000 | ||||||||||||||||